Salivary cortisol levels as a biomarker for severity of withdrawal in opioid-exposed newborns.

CONCLUSIONS: Salivary cortisol in opioid-exposed newborns may provide an index of stress and help identify infants who will have more severe clinical presentation of NAS. Such a biomarker would allow risk stratification for early treatment and discharge decisions. PMID: 31578040 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31578040?dopt=Abstract

Source: Pediatric Research - October 1, 2019 Category: Pediatrics Authors: Rodriguez N, Vining M, Bloch-Salisbury E Tags: Pediatr Res Source Type: research

More News: Pediatrics | Perinatology & Neonatology | Study